Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Cervical Cancer

Free Subscription Articles published in Oncol Rep Retrieve available abstracts of 17 articles: HTML format

Single Articles

June 2026
1. LEUNG RC, Liu SS, Chan KY, Tam KF, et al
   [Expression of Concern] Promoter methylation of death?associated protein kinase and its role in irradiation response in cervical cancer.
   Oncol Rep. 2026;55:120.
   PubMed     Abstract available
   
   
   May 2026
2. LUO R, Chen J, Chen Z, Wang S, et al
   MS4322 is a selective protein arginine methyltransferase 5 degrader with antitumor effects in cervical cancer cells.
   Oncol Rep. 2026;55:101.
   PubMed     Abstract available
   
   
   January 2026
3. LIU S, Pan X, Yang Q, Wen L, et al
   [Retracted] MicroRNA?18a enhances the radiosensitivity of cervical cancer cells by promoting radiation?induced apoptosis.
   Oncol Rep. 2026;55:18.
   PubMed     Abstract available
   
   
   
4. LEUNG RC, Liu SS, Chan KY, Tam KF, et al
   [Expression of Concern] Promoter methylation of death?associated protein kinase and its role in irradiation response in cervical cancer.
   Oncol Rep. 2026;55:23.
   PubMed     Abstract available
   
   
   October 2025
5. LI X, Zhou M, Yu J, Yu S, et al
   Histone modifications in cervical cancer: Epigenetic mechanisms, functions and clinical implications (Review).
   Oncol Rep. 2025;54:131.
   PubMed     Abstract available
   
   
   September 2025
6. ZHANG C, Fan X, Yang J, Zhu P, et al
   EIF3B?METTL3 complex promotes cell proliferation, invasion and EGFR/AKT signaling in cervical cancer.
   Oncol Rep. 2025;54:103.
   PubMed     Abstract available
   
   
   June 2025
7. FRIEDLOVA N, Bortlikova L, Dosedelova L, Uhrik L, et al
   IFITM1 as a modulator of surfaceome dynamics and aggressive phenotype in cervical cancer cells.
   Oncol Rep. 2025;53:71.
   PubMed     Abstract available
   
   
   August 2024
8. ZHOU Y, Xie Y, Luo Y, Wang S, et al
   SNAI2 enhances HPV?negative cervical cancer cell dormancy by modulating u?PAR expression and the activity of the ERK/p38 signaling pathway in vitro.
   Oncol Rep. 2024;52:104.
   PubMed     Abstract available
   
   
   June 2024
9. LI W, Liang J, Zhang Z, Lou H, et al
   [Retracted] MicroRNA?329?3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer.
   Oncol Rep. 2024;51:86.
   PubMed     Abstract available
   
   
   April 2024
10. SHI C, Zhang Z
    [Retracted] MicroRNA?362 is downregulated in cervical cancer and inhibits cell proliferation, migration and invasion by directly targeting SIX1.
    Oncol Rep. 2024;51:54.
    PubMed     Abstract available
    
    
    December 2023
11. LIU Z, Zhang H, Hu X
    Analysis of the expression and mechanism of follistatin?like protein 1 in cervical cancer.
    Oncol Rep. 2023;50:215.
    PubMed     Abstract available
    
    
    November 2023
12. LIANG H, Luo R, Chen X, Zhao Y, et al
    [Retracted] miR?187 inhibits the growth of cervical cancer cells by targeting FGF9.
    Oncol Rep. 2023;50:195.
    PubMed     Abstract available
    
    
    July 2023
13. LI M, Gao Z, Wang S, Zhao Y, et al
    miR‑27a‑3p upregulation by p65 facilitates cervical tumorigenesis by increasing TAB3 expression and is involved in the positive feedback loop of NF‑kappaB signaling.
    Oncol Rep. 2023;50:132.
    PubMed     Abstract available
    
    
    June 2023
14. YANG J, Gao Y, Yao S, Wan S, et al
    TFAP2A promotes cervical cancer via a positive feedback pathway with PD‑L1.
    Oncol Rep. 2023;49:114.
    PubMed     Abstract available
    
    
    
15. NDIAYE M, Diop G, Derbois C, Spadoni JL, et al
    Gene expression profiling of peripheral blood mononuclear cells from women with cervical lesions reveals new markers of cancer.
    Oncol Rep. 2023;49:118.
    PubMed     Abstract available
    
    
    May 2023
16. CAUSIN RL, Van Helvoort Lengert A, Gomes INF, De Freitas AJA, et al
    MicroRNA‑130a‑3p inhibition suppresses cervical cancer cell progression.
    Oncol Rep. 2023;49:109.
    PubMed     Abstract available
    
    
    March 2021
17. QIN K, Jian D, Xue Y, Cheng Y, et al
    DDX41 regulates the expression and alternative splicing of genes involved in tumorigenesis and immune response.
    Oncol Rep. 2021;45:1213-1225.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum